Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site

Journal of Virology

Volumn 70, Issue 10, 1996, Pages 6937-6946

  Schafer, Susan L ^a   Vlach, Jaromir ^a,c   Pitha, Paula M ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

7 CHLORO 1,3 DIHYDRO 5 (2 PYRROLYL) 2H 1,4 BENZODIAZEPIN 2 ONE;

ARTICLE; CONTROLLED STUDY; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMEDIATE EARLY GENE; LEUKEMIA CELL LINE; LONG TERMINAL REPEAT; PRIORITY JOURNAL; TRANSACTIVATION; VIRUS TRANSCRIPTION;

EID: 0029839687     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.10.6937-6946.1996     Document Type: Article

References (95)

1. + lymphocytes. J. Virol. 63:1861-1868.
2. Alcami, J., T. Lain de Lera, L. Folgueira, M. A. Pedraza, J. M. Jacque, F. Bachelerie, A. R. Noriega, R. T. Hay, D. Harrich, R. B. Gaynor, J. L. Virelizier, and F. Arezana-Seisdedos. 1995. Absolute dependence on kB responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J. 14:1552-1560.
3. Arrigo, S. J., and I. S. Y. Chen. 1991. Rev is necessary for translation hut not cytoplasmic accumulation of HIV-1 vif. vpr, and env/vpu 2 RNAs. Genes Dev. 5:808-819.
4. Bagasra, O., K. Khalili, T. Seshamma, J. P. Taylor, and R. J. Pomerantz. 1992. TAR-independent replication of human immunodeficiency virus type 1 in glial cells. J. Virol. 66:7522-7528.
5. Benko, D. M., R. Robinson, L. Solomin, M. Mellini, B. K. Felber, and G. N. Pavlakis. 1990. Binding of trans-dominant mutant rev protein of human immunodeficiency virus type 1 to the cis-acting rev responsive element does not affect the fate of viral mRNA. New Biol. 2:1111-1122.
6. Berkhout, B., A. B. Gatignol, A. Rabson, and K.-T. Jeang. 1990. TAR-independent activation of the HIV-1 LTR: evidence that Tat requires specific regions of the promoter. Cell 62:757-768.
7. Berkhout, B., and K.-T. Jeang. 1992. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 66:139-149.
8. Braddock, M., P. Cannon, M. Muckenthaler, A. J. Kingsman, and S. M. Kingsman. 1994. Inhibition of human immunodeficiency virus type 1 Tat-dependent activation of translation in Xenopus oocytes by the benzodiazepine Ro24-7429 requires trans-activation response element loop sequences. J. Virol. 68:25-33.
9. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
10. Buonaguro, L., G. Barillari, H. K. Chang, C. A. Bohan, V. Kao, R. Morgan, R. C. Gallo, and B. Ensoli. 1992. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J. Virol. 66:7159-7168.
11. Carroll, R., L. Martarano, and D. Derse. 1991. Identification of lentivirus Tat functional domains through generation of equine infectious anemia virus/human immunodeficiency virus type 1 tat gene chimeras. J. Virol. 65:3460-3468.
12. Carroll, R., B. M. Peterlin, and D. Derse. 1992. Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans activators. J. Virol. 66:2000-2007.
13. Chan, W.-L., M. L. V. Tizard, and L. Faulkner. 1989. Proliferative T-cell response to glycoprotein B of the human herpes viruses: the influence of MHC and sequence of infection on the pattern of cross-reactivity. Immunology 68:96-101.
14. Chapman, C. J., J. D. Harris, M. K. L. Collins, and D. S. Latchman. 1991 A recombinant HIV provirus is synergistically activated by the HIV Tat protein and the HSV IE1 protein but not by the HSV IE3 protein. J. Acquired Immune Defic. Syndr. 5:945-951.
15. Chen, J. X., X. X. Zhu, and S. Silverstein. 1991. Mutational analysis of the sequence encoding ICP0 from herpes simplex virus type 1. Virology 180: 207-220.
16. L, in cells derived from central nervous system. Oncogene 8:887-892.
17. Ciufo, D. M., M.-A. Mullen, and G. S. Hayward. 1994. Identification of a dimerization domain in the C-terminal segment of the IE110 transactivator protein from herpes simplex virus. J. Virol. 68:3268-3283.
18. Clouse, K. A., D. Powell, I. Washington, G. Poli, K. Strebel, W. Farrar, P. Barstad, J. Kovacs, A. S. Fauci, and T. M. Folks. 1989. Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T-ccll line. J. Immunol. 142:431-438.
19. D'Agostino, D. M., B. K. Felber, J. E. Harrison, and G. N. Pavlakis. 1992. The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs. Mol. Cell. Biol. 12:1375-1386.
20. Dayton, A. I., J. G. Sodroski, C. A. Rosen, W. C. Goh, and W. A. Haseltine. 1986. The trans-activation gene of the human T-cell lymphotropic virus type III is required for replication. Cell 44:941-947.
21. Derse, D., M. Carvalho, R. Carroll, and B. M. Peterlin. 1991. A minimal lentivirus Tat. J. Virol. 65:7012-7015.
22. Desai, K., P. M. Loewenstein, and M. Green. 1991. Isolation of a cellular protein that binds to the human immunodeficiency virus tat protein and can potentiate transactivation of the promoter. Proc. Natl. Acad. Sci. USA 88: 8875-8879.
23. Dub, E. J., W. J. Maury, T. M. Folks, A. S. Fauci, and A. B. Rabson. 1989. Tumor necrosis factor α activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κB sites in the long terminal repeat. Proc. Natl. Acad. Sci. USA 86:5974-5978.
24. Everett, R. D., C. M. Preston, and N. D. Stow. 1991. Functional and genetic analysis of the role of Vmw110 in herpes simplex virus replication, p. 49-76. In E. K. Wager (ed.), Herpesvirus transcription and its regulation. CRC Press, Inc., Boca Raton, Fla.
25. Feinberg, M. B., D. Baltimore, and A. D. Frankel. 1991. The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc. Natl. Acad. Sci. USA 88:4045-4049.
26. Feinberg, M. G., R. F. Jarret, A. Aldovini, R. C. Gallo, and F. Wong-Staal. 1986. HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell 46:807-817.
27. Felber, B. K., M. Hadzopoulou-Cladaras, C. Cladaras, T. Copeland, and G. N. Pavlakis. 1989. rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl. Acad. Sci. USA 86:1495-1499.
28. Folks, T., S. Benn, A. Rabson, T. Theodore, M. D. Hoggan, M. Martin, M. Lightfoote, and K. Sell. 1985. Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus. Proc. Natl. Acad. Sci. USA 83:4539-4543.
29. Garcia, J. A., D. Harrich, L. Pearson, R. Mitsuyasu, and R. B. Gaynor. 1988. Functional domains required for tat-induced transcriptional activation of the HIV-1 long terminal repeat. EMBO J. 7:3143-3147.
30. Gimble, J. M., E. Duh, J. M. Ostrove, H. E. Gendelman, E. E. Max, and A. B. Rabson. 1988. Activation of the human immunodeficiency virus long terminal repeat by herpes simplex virus type 1 is associated with induction of a nuclear factor that binds to the NF-κB/core enhancer sequence. J. Virol. 62:4104-4112.
31. Golden, M. P., S. Kim, S. M. Hammer, E. A. Ladd, P. A. Schaffer, N. DeLuca, and M. A. Albrecht. 1992. Activation of human immunodeficiency virus by herpes simplex virus. J. Infect. Dis. 166:494-499.
32. Griffin, G. E., K. Leung, T. M. Folks, S. Kunkel, and G. J. Nabel. 1989. Activation of HIV gene expression during monocyte differentiation by induction of NF-κB. Nature (London) 339:70-73.
33. Hadzopoulou-Cladaras, M., B. K. Felber, C. Cladaras, A. Athanassopoulous, A. Tse, and G. N. Pavlakis. 1989. The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region. J. Virol. 63:1265-1274.
34. Hammarskjöld, M.-L., J. Heimer, B. Hammarskjöld. I. Sangwan, L. Albert, and D. Rekosh. 1989. Regulation of human immunodeficiency virus env expression by the rev gene product. J. Virol. 63:1959-1966.
35. Harrich, D., J. Garcia, R. Mitsuyasu, and R. Gaynor. 1990. TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes. EMBO J. 9:4417-4423.
36. Ho, W. Z., J. M. Harouse, R. F. Rando, E. Gonczol, A. Srinivasan, and S. A. Plotkin. 1990. Reciprocal enhancement of gene expression and viral replication between human cytomegalovirus and human immunodeficiency virus type 1. J. Gen. Virol. 71:97-103.
37. Hsu, M.-C., A. D. Schutt, M. Holly, L. W. Slice, M. I. Sherman, D. D. Richman, M. J. Potash, and D. J. Volsky. 1991. Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist. Science 254: 1799-1802.
38. Israel, N., U. Hazan, J. Alcami, A. Munier, F. Arenzana-Seisdedos, F. Bachelerie, A. Israel, and J.-L. Virelizier. 1989. Tumor necrosis factor stimulates transcription of HIV-1 in human T lymphocytes, independently and synergistically with mitogens. J. Immunol. 143:3956-3960.
39. Jeang, K.-T., R. Chun, N. H. Lin, A. Gatignol, C. G. Glabe, and H. Fan. 1993. In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor. J. Virol. 67:6224-6233.
40. Kashanchi, F., G. Pivas, M. F. Radonovich, J. F. Duvall, A. Fattaey, C.-M. Chiang, R. Roeder, and J. N. Brady. 1994. Direct interaction of human TFIID with the HIV-1 transactivator Tat. Nature (London) 367:295-299.
41. Kato, H., H. Sumimoto, P. Pognonee, C.-H. Chen, C. A. Rosen, and R. G. Roeder. 1992. HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. Genes Dev. 6:655-666.
42. Kenney, S., J. Kamine, D. Markovitz, R. Fenrick, and J. Pagano. 1988. An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat. Proc. Natl. Acad. Sci. USA 85:1652-1656.
43. Kim, Y.-S., and R. Risser. 1993. TAR-independent transactivation of the murine cytomegalovirus major immediate-early promoter by the Tat protein. J. Virol. 67:239-248.
44. Kowalik, T. F., B. Wing, J. S. Haskill, J. C. Azizkhan, A. S. Baldwin, Jr., and E.-S. Huang. 1993. Multiple mechanisms are implicated in the regulation of NF-κB activity during human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 90:1107-1111.
45. Kuppuswamy, M., T. Subramanian, A. Srinivasana, and G. Chinnaduurai. 1989. Multiple functional domains of Tat, the transactivator of HIV-1, defined by mutational analysis. Nucleic Acids Res. 17:3551-3561.
46. Laspia, M. F., A. P. Rice, and M. B. Mathews. 1989. HIV-1 tat protein increases transcriptional initiation and stabilizes elongation. Cell 59:283-292.
47. Laspia, M. F., A. P. Rice, and M. B. Mathews. 1990. Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation. Genes Dev. 4:2397-2408.
48. Liu, J., N. D. Perkins, R. M. Schmid, and G. J. Nabel. 1992. Specific NF-κB subunits act in concert with Tat to stimulate human immunodeficiency virus type 1 transcription. J. Virol. 66:3883-3887.
49. Lu, X., T. M. Welsh, and B. M. Pelerlin. 1993. The human immunodeficiency virus type 1 long terminal repeat specifies two different transcription complexes, only one of which is regulated by Tat. J. Vitol. 67:1752-1760.
50. Lusso, P., M. S. Malnati, A. Garzino-Demo, R. V. Crowley, E. O. Long, and R. C. Gallo. 1993. Infection of natural killer cells by human herpes virus 6. Nature (London) 362:458-462.
51. MacGregor, G. R., and C. T. Casky. 1989. Construction of plasmids that express E. coli β-galactosidase in mammalian cells. Nucleic Acids Res. 17: 2365.
52. Madore, S. J., and B. R. Cullen. 1993. Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function. J. Virol. 67:3703-3711.
53. Madore, S. J., and B. R. Cullen. 1995. Functional similarities between HIV-1 Tat and DNA sequence-specific transcriptional activators. Virology 206: 1160-1154.
54. Maldarelli, F., M. A. Martin, and K. Strebel. 1991. Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation. J. Virol. 65:5732-5743.
55. Malim, M. H., J. Hauber, S.-Y. Le, J. V. Maizel, and B. R. Cullen. 1989 The HIV-1 rev transactivator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature (London) 338:254-257.
56. Marciniak, R. A., and P. A. Sharp. 1991. HIV-1 Tar protein promotes formation of more-processive elongation complexes. EMBO J. 10:4189-4196.
57. Margolis, D. M., J. M. Ostrove, and S. E. Straus. 1993. HSV-1 activation of HIV-1 transcription is augmented by a cellular protein that binds near the initiator element. Virology 192:370-374.
58. Mosca, J. D., D. P. Bednarik, N. B. K. Raj, C. A. Rosen, J. G. Sodroski, W. A. Haseltine, G. S. Hayward, and P. M. Pitha. 1987. Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1. Proc. Natl. Acad. Sci. USA 84:7408-7412.
59. Mosca, J. D., D. P. Bednarik, N. B. K. Raj, C. A. Rosen, J. G. Sodroski, W. A. Haseltine, and P. M. Pitha. 1987. Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus. Nature (London) 325:68-70.
60. Mosea, J. D., P. M. Pitha, and G. S. Hayward. 1992. Herpes simplex virus infection selectively stimulates accumulation of beta Interferon reporter gene mRNA by a posttranscriptional mechanism. J. Virol. 66:3811-3822.
61. Mullen, M.-A., D. M. Ciufo, and G. S. Hayward. 1994. Mapping of intracellular localization domains and evidence for colocalization interactions between the IE110 and IE175 nuclear transactivator proteins of herpes simplex virus. J. Virol. 68:3250-3266.
62. Nabel, G. J., S. A. Rice, D. M. Knipe, and D. Baltimore. 1988. Alternative mechanisms for activation of human immunodeficiency virus enhancer in T cells. Science 239:1299-1302.
63. Nelbock, P., P. J. Dillon, A. Perkins, and C. A. Rosen. 1990. A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator. Science 248:1650-1653.
64. O'Hare, P., and G. S. Hayward. 1987. Comparison of upstream sequence requirements for positive and negative regulation of a herpes simplex virus immediate-early gene by three virus-encoded trans-acting factors. J. Virol. 61:190-199.
65. Olsen, H. S., and C. A. Rosen. 1992. Contribution of the TATA motif to Tat-mediated transcriptional activation of human immunodeficiency virus gene expression. J. Virol. 66:5594-5597.
66. Osborn, L., S. Kunkel, and G. J. Nabel. 1989. Tumor necrosis factor α and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB. Proc. Natl. Acad. Sci. USA 86:2336-2340.
67. Ostrove, J. M., J. Leonard, K. E. Week, A. B. Rabson, and H. E. Gendelman. 1987. Activation of the human immunodeficiency virus by herpes simplex virus type 1. J. Virol. 61:3726-3732.
68. Pitha, P. M., and D. P. Bednarik. 1990. Transactivation of the human immunodeficiency virus (HIV) promoter by heterologous virus infection, p. 290-308. In L. Aurelian (ed.), Herpesviruses, the immune system, and AIDS. Kluwer, Boston.
69. Popik, W., and P. M. Pitha. 1992. Transcriptional activation of the Tat-defective human immunodeficiency virus type-1 provirus: effect of interferon. Virology 189:435-447.
70. Popik, W., and P. M. Pitha. 1993. Role of tumor necrosis factor alpha in activation and replication of the tat-defective human immunodeficiency virus type 1. J. Virol. 67:1094-1099.
71. Raj, N. B. K., and P. M. Pitha. 1981. Analysis of interferon message RNA in human fibroblast cells induced to produce interferon. Proc. Natl. Acad. Sci. USA 78:7426-7430.
72. Rice, A. P., and F. Carlotti. 1990. Structural analysis of wild-type and mutant human immunodeficiency virus type 1 Tat proteins. J. Virol. 64:6018-6026.
73. Roberts, M. S., A. Boundy, P. O'Hare, M. C. Pizzorno, D. M. Ciufo, and G. S. Hayward. 1988. Direct correlation between a negative autoregulatory response element at the cap site of the herpes simplex virus type 1 IE175 (α4) promoter and a specific binding site for the IE175 (ICP4) protein. J. Virol. 62:4307-4320.
74. Roy, S., U. Delling, C.-H. Chen, C. A. Rosen, and N. Sonenberg. 1990. A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation. Genes Dev. 4:1365-1373.
75. Ruben, S., A. Perkins, R. Purcell, K. Joung, R. Sia, R. Burghoff, W. A. Haseltine, and C. A. Rosen. 1989. Structural and functional characterization of human immunodeficiency virus tat protein. J. Virol. 63:1-8.
76. Schwartz, S., B. K. Felber, and G. N. Pavlakis. 1992. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein. J. Virol. 66:150-159.
77. Selby, M. J., and B. M. Peterlin. 1990. Trans-activation by HIV-1 Tat via a heterologous RNA binding protein. Cell 62:769-776.
78. Smiley, J. R., B. Panning, and C. A. Smibert. 1991. Regulation of cellular genes by HSV products, p. 151. In E. K. Wagner (ed.), Herpesvirus transcription and its regulation. CRC Press, Inc., Boca Raton, Fla.
79. Sodroski, J., W.-C. Goh, C. Rosen, A. Dayton, E. Terwilliger, and W. Haseltine. 1986. A second post-transcriptional trans-activator gene required for HTLV-III replication. Nature (London) 321:412-417.
80. Sodroski, J., C. Rosen, F. Wong-Staal, S. A. Salahuddin, M. Popovic, S. Arya, R. C. Gallo, and W. A. Haseltine. 1985. Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat. Science 227:171-173.
81. Song, C.-Z., P. M. Loewenstein, and M. Green. 1994. Transcriptional activation in vitro by the human immunodeficiency virus type 1 Tat protein: evidence for specific interaction with a coactivator(s). Proc. Natl. Acad. Sci. USA 91:9357-9361.
82. Southgate, C. D., and M. R. Green. 1991. The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function. Genes Dev. 5:2496-2507.
83. Su, Y., W. Popik, and P. M. Pitha. 1995. Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced Interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells. J. Virol. 69:110-121.
84. Sullenger, B. A., H. F. Gallardo, G. E. Ungers, and E. Gilboa. 1991. Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation. J. Virol. 65:6811-6816.
85. Tansey, W. P., and W. Herr. 1995. The ability to associate with activation domains in vitro is not required for the TATA box-binding protein to support activated transcription in vivo. Proc. Natl. Acad. Sci. USA 92:10550-10554.
86. Taylor, J. P., R. Pomerantz, O. Bagasra, M. Chowdhury, J. Rappaport, K. Khalili, and S. Amini. 1992. TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation. EMBO J. 11:3395-3403.
87. Tiley, L. S., P. H. Brown, and B. R. Cullen. 1990. Does the human immunodeficiency virus Tat trans-activator contain a discrete activation domain? Genes Dev. 6:2077-2087.
88. Vlach, J., and P. M. Pitha. 1992. Herpes simplex virus type 1-mediated induction of human immunodeficiency virus type 1 provirus correlates with binding of nuclear proteins to the NF-κB enhancer and leader sequence. J. Virol. 66:3616-3623.
89. Vlach, J., and P. M. Pitha. 1993. Differential contribution of herpes simplex virus type 1 gene products and cellular factors to the activation of human immunodeficiency virus type 1 provirus. J. Virol. 67:4427-4431.
90. Vlach, J., and P. M. Pitha. Unpublished data.
91. Vlach, J., K. W. Wilcox, and P. M. Pitha. 1994. Herpes-simplex-virus-infected cells produce a protein that binds to the TAR DNA region of the human immunodeficiency virus type 1 long terminal repeat. J. Biomed. Sci. 1:209-217.
92. Weber, P. C., J. J. Kenny, and B. Wigdahl. 1992. Antiviral properties of a dominant negative mutant of the herpes simplex virus type 1 regulatory protein ICP0. J. Gen. Virol. 73:2955-2961.
93. Wu, F., J. Garcia, D. Sigman, and R. Gaynor. 1991. Tat regulates binding of the human immunodeficiency virus transactivating region RNA loop-binding protein TRP-185. Genes Dev. 5:2128-2140.
94. Zhong, F., S. L. Swendeman, W. Popik, P. M. Pitha, and M. Sheffery. 1994. Evidence that levels of the dimeric cellular transcription factor CP2 play little role in the activation of the HIV-1 long terminal repeat in vivo or following superinfection with herpes simplex virus type 1. J. Biol. Chem. 269:21269-21276.
95. Zhu, X. X., C. S. Chen, and A. S. Huang. 1990. Phenotypic mixing between human immunodeficiency virus and vesicular stomatitis virus or herpes simplex virus. AIDS 3:215-219.